Works matching AU Hammarstedt, Ann

Results: 34
    1

    Effects of dapagliflozin on sodium excretion, blood pressure and volume status in patients with type 2 diabetes and/or chronic kidney disease: The DAPASALT trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 8, p. 4415, doi. 10.1111/dom.16478
    By:
    • Beernink, Jelle M.;
    • Jongs, Niels;
    • Mosterd, Charlotte M.;
    • Scholtes, Rosalie A.;
    • Caldwell‐McGee, Alyssa;
    • Casillas, Daniel;
    • Driscoll, Lynette;
    • Greasley, Peter J.;
    • Karlsson, Cecilia;
    • Hammarstedt, Ann;
    • Sridhar, Vikas S.;
    • Muskiet, Marcel H. A.;
    • Laverman, Gozewijn D.;
    • Cherney, David Z. I.;
    • Bjornstad, Petter;
    • van Raalte, Daniel H.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    2

    Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.

    Published in:
    Diabetes, Obesity & Metabolism, 2022, v. 24, n. 8, p. 1578, doi. 10.1111/dom.14729
    By:
    • Sen, Taha;
    • Scholtes, Rosalie;
    • Greasley, Peter J.;
    • Cherney, David Z. I.;
    • Dekkers, Claire C. J.;
    • Vervloet, Marc;
    • Danser, Alexander H. J.;
    • Barbour, Sean J.;
    • Karlsson, Cecilia;
    • Hammarstedt, Ann;
    • Li, Qiang;
    • Laverman, Gozewijn D.;
    • Bjornstad, Petter;
    • van Raalte, Daniel H.;
    • Heerspink, Hiddo J. L.
    Publication type:
    Article
    3
    4

    <bold>CCN5/W</bold>ISP2 and metabolic diseases.

    Published in:
    Journal of Cell Communication & Signaling, 2018, v. 12, n. 1, p. 309, doi. 10.1007/s12079-017-0437-z
    By:
    • Grünberg, John R;
    • Elvin, Johannes;
    • Paul, Alexandra;
    • Hedjazifar, Shahram;
    • Hammarstedt, Ann;
    • Smith, Ulf
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Single-nucleotide polymorphism rs7754840 of CDKAL1 is associated with impaired insulin secretion in nondiabetic offspring of type 2 diabetic subjects and in a large sample of men with normal glucose tolerance.

    Published in:
    2008
    By:
    • Stancáková, Alena;
    • Pihlajamäki, Jussi;
    • Kuusisto, Johanna;
    • Stefan, Norbert;
    • Fritsche, Andreas;
    • Häring, Hans;
    • Andreozzi, Francesco;
    • Succurro, Elena;
    • Sesti, Giorgio;
    • Boesgaard, Trine Welløv;
    • Hansen, Torben;
    • Pedersen, Oluf;
    • Jansson, Per Anders;
    • Hammarstedt, Ann;
    • Smith, Ulf;
    • Laakso, Markku;
    • EUGENE2 Consortium
    Publication type:
    journal article
    14

    Retinol-Binding Protein 4 Inhibits Insulin Signaling in Adipocytes by Inducing Proinflammatory Cytokines in Macrophages through a c-Jun N-Terminal Kinase- and Toll-Like Receptor 4-Dependent and Retinol-Independent Mechanism.

    Published in:
    Molecular & Cellular Biology, 2012, v. 32, n. 10, p. 2010, doi. 10.1128/MCB.06193-11
    By:
    • Norseen, Julie;
    • Hosooka, Tetsuya;
    • Hammarstedt, Ann;
    • Yore, Mark M.;
    • Kant, Shashi;
    • Aryal, Pratik;
    • Kiernan, Urban A.;
    • Phillips, David A.;
    • Maruyama, Hiroshi;
    • Kraus, Bettina J.;
    • Usheva, Anny;
    • Davis, Roger J.;
    • Smith, Ulf;
    • Kahn, Barbara B.
    Publication type:
    Article
    15

    Epigenetic modifications of the Zfp/ ZNF423 gene control murine adipogenic commitment and are dysregulated in human hypertrophic obesity.

    Published in:
    Diabetologia, 2018, v. 61, n. 2, p. 369, doi. 10.1007/s00125-017-4471-4
    By:
    • Longo, Michele;
    • Raciti, Gregory A.;
    • Zatterale, Federica;
    • Parrillo, Luca;
    • Desiderio, Antonella;
    • Spinelli, Rosa;
    • Hammarstedt, Ann;
    • Hedjazifar, Shahram;
    • Hoffmann, Jenny M.;
    • Nigro, Cecilia;
    • Mirra, Paola;
    • Fiory, Francesca;
    • Formisano, Pietro;
    • Miele, Claudia;
    • Smith, Ulf;
    • Beguinot, Francesco
    Publication type:
    Article
    16
    17

    Effects of dapagliflozin and dapagliflozin-saxagliptin on erythropoiesis, iron and inflammation markers in patients with type 2 diabetes and chronic kidney disease: data from the DELIGHT trial.

    Published in:
    Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-02027-8
    By:
    • Koshino, Akihiko;
    • Neuen, Brendon L.;
    • Jongs, Niels;
    • Pollock, Carol;
    • Greasley, Peter J.;
    • Andersson, Eva-Marie;
    • Hammarstedt, Ann;
    • Karlsson, Cecilia;
    • Langkilde, Anna Maria;
    • Wada, Takashi;
    • Heerspink, Hiddo J.L.
    Publication type:
    Article
    18
    19

    A novel cellular marker of insulin resistance and early atherosclerosis in humans is related to impaired fat cell differentiation and low adiponectin.

    Published in:
    FASEB Journal, 2003, v. 17, n. 11, p. 1434, doi. 10.1096/fj.02-1132com
    By:
    • Jansson, Per-Anders;
    • Pellme, Fredrik;
    • Hammarstedt, Ann;
    • Sandqvist, Madelene;
    • Brekke, Hilde;
    • Caidahl, Kenneth;
    • Forsberg, Margareta;
    • Volkman, Reinhard;
    • Carvalho, Eugenia;
    • Funahashi, Tohru;
    • Matsuzawa, Yuji;
    • Wiklund, Olle;
    • Yang, Xiaolin;
    • Taskinen, Marja-Riitta;
    • Smith, Ulf
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF.

    Published in:
    European Journal of Heart Failure, 2022, v. 24, n. 6, p. 1066, doi. 10.1002/ejhf.2433
    By:
    • McDowell, Kirsty;
    • Welsh, Paul;
    • Docherty, Kieran F.;
    • Morrow, David A.;
    • Jhund, Pardeep S.;
    • de Boer, Rudolf A.;
    • O'Meara, Eileen;
    • Inzucchi, Silvio E.;
    • Køber, Lars;
    • Kosiborod, Mikhail N.;
    • Martinez, Felipe A.;
    • Ponikowski, Piotr;
    • Hammarstedt, Ann;
    • Langkilde, Anna Maria;
    • Sjöstrand, Mikaela;
    • Lindholm, Daniel;
    • Solomon, Scott D.;
    • Sattar, Naveed;
    • Sabatine, Marc S.;
    • McMurray, John J.V.
    Publication type:
    Article
    31

    Adult mice are unresponsive to AAV8-Gremlin1 gene therapy targeting the liver.

    Published in:
    PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0247300
    By:
    • Khatib Shahidi, Roxana;
    • M. Hoffmann, Jenny;
    • Hedjazifar, Shahram;
    • Bonnet, Laurianne;
    • K. Baboota, Ritesh;
    • Heasman, Stephanie;
    • Church, Christopher;
    • Elias, Ivet;
    • Bosch, Fatima;
    • Boucher, Jeremie;
    • Hammarstedt, Ann;
    • Smith, Ulf
    Publication type:
    Article
    32
    33

    Overexpressing the novel autocrine/endocrine adipokine WISP2 induces hyperplasia of the heart, white and brown adipose tissues and prevents insulin resistance.

    Published in:
    Scientific Reports, 2017, p. 43515, doi. 10.1038/srep43515
    By:
    • Grünberg, John R.;
    • Hoffmann, Jenny M.;
    • Hedjazifar, Shahram;
    • Nerstedt, Annika;
    • Jenndahl, Lachmi;
    • Elvin, Johannes;
    • Castellot, John;
    • Wei, Lan;
    • Movérare-Skrtic, Sofia;
    • Ohlsson, Claes;
    • Holm, Louise Mannerås;
    • Bäckhed, Fredrik;
    • Syed, Ismail;
    • Bosch, Fatima;
    • Saghatelian, Alan;
    • Kahn, Barbara B.;
    • Hammarstedt, Ann;
    • Smith, Ulf
    Publication type:
    Article
    34